IGC Pharma (IGC) Tax Rate (2010 - 2024)
IGC Pharma's (IGC) quarterly Tax Rate came in at 94.63% in Q1 2024, up 3468.0% year-over-year from 2.65% in Q2 2023, and up 57.84% quarter-over-quarter from 59.95% in Q1 2023.
Analysis
IGC Pharma (IGC) Tax Rate (2010 - 2024) Analysis & Trends
IGC Pharma (IGC) has reported Tax Rate for 14 consecutive years, with 94.63% the latest figure, recorded in Q1 2024.
- On a quarterly basis, Tax Rate rose 3468.0% year-over-year to 94.63% in Q1 2024; TTM through Dec 2024 was 30.99%, a 1391.0% increase from a year earlier, with the FY2025 full-year figure at 32.37%, up 1137.0% from the prior year.
- Tax Rate was 94.63% for Q1 2024 at IGC Pharma, up from 59.95% in the prior quarter.
- Over five years, Tax Rate peaked at 97.81% in Q1 2020 and troughed at 48.49% in Q1 2022.
- A 5-year average of 72.72% and a median of 62.73% in 2021 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate soared 15238 bps in 2020 and sank 3508 bps in 2021, its largest moves.
- Over 5 years, Tax Rate stood at 97.81% in 2020, then plunged by 36 bps to 62.73% in 2021, then retreated by 23 bps to 48.49% in 2022, then gained by 24 bps to 59.95% in 2023, then surged by 58 bps to 94.63% in 2024.
- The last three Tax Rate figures came in at 94.63% (Q1 2024), 59.95% (Q1 2023), and 48.49% (Q1 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.74 Bn | 192.75 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 179.96 Bn | 176.78 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 131.20 Bn | 123.35 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.05 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.08 Bn | 29.78 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.91 Bn | 30.62 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.22 Bn | 29.22 Bn | 1.16 Mn | 1.34% |
| 10 | IGC Pharma | 27.58 Mn | 27.32 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 94.63% |
| Mar 31, 2023 | 59.95% |
| Mar 31, 2022 | 48.49% |
| Mar 31, 2021 | 62.73% |
| Mar 31, 2020 | 97.81% |
| Mar 31, 2019 | -54.57% |
| Mar 31, 2017 | 57.00% |
| Dec 31, 2016 | -99.36% |
| Mar 31, 2016 | 187.27% |
| Dec 31, 2015 | -100.04% |
| Mar 31, 2015 | 81.42% |
| Mar 31, 2014 | 69.59% |
| Dec 31, 2013 | -0.62% |
| Sep 30, 2013 | -0.25% |
| Jun 30, 2013 | -0.25% |
| Mar 31, 2013 | 31.09% |
| Dec 31, 2012 | -0.09% |
| Sep 30, 2012 | -6.27% |
| Jun 30, 2012 | 5.54% |
| Mar 31, 2012 | 63.26% |